ArticleOncoTargets and therapy2018

Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma.

Marta Garcia-Recio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.